ArticleProceedings of the National Academy of Sciences of the United States of America2025

Thiopurine therapy enhances immune checkpoint inhibitor efficacy in low-mutational burden melanoma: A promising anticancer approach.

Loulieta Nazerai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.